Malantide TFA
Product Specifications
Target
PKA, PKC
Related Pathways
Chromatin/Epigenetic, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors
Bioactivity
Malantide TFA, a synthetic dodecapeptide, originates from the phosphorylation site targeted by cAMP-dependent protein kinase (PKA) on the β-subunit of phosphorylase kinase. Exhibiting a high specificity for PKA with a Michaelis constant (Km) of 15 μM, this compound demonstrates more than 90% inhibition of substrate phosphorylation in the presence of protein inhibitor (PKI) across various rat tissue extracts [1]. Moreover, Malantide TFA acts as an effective substrate for Protein Kinase C (PKC) with a Km of 16 μM [2].
Molecular Formula
C74H125F3N22O23
Molecular Weight
1747.91
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2404-06K1-01 100 µg
CD49b (CD49b Antigen, Alpha 2 Subunit of VLA2 Receptor, Alpha 2 Subunit of VLA-2 Receptor, Collagen Receptor, GPIa, Integrin alpha 2, ITGA2, Platelet Antigen Br, Platelet Glycoprotein GPIa, Platelet Glycoprotein Ia, Platelet Membrane Glycoprotein Ia, Very Late Activation Protein 2 Receptor alpha 2 Subunit, VLA2 alpha chain, VLA2, VLA-2 alpha chain, VLA-2, VLAA2)
Sign In for Pricing
View Details 
C2404-06K1-02 200 µg
CD49b (CD49b Antigen, Alpha 2 Subunit of VLA2 Receptor, Alpha 2 Subunit of VLA-2 Receptor, Collagen Receptor, GPIa, Integrin alpha 2, ITGA2, Platelet Antigen Br, Platelet Glycoprotein GPIa, Platelet Glycoprotein Ia, Platelet Membrane Glycoprotein Ia, Very Late Activation Protein 2 Receptor alpha 2 Subunit, VLA2 alpha chain, VLA2, VLA-2 alpha chain, VLA-2, VLAA2)
Sign In for Pricing
View Details abx005681-01 60 µL
ATP Synthase Subunit O, Mitochondrial (ATP5O) Antibody
Sign In for Pricing
View Details 
abx005681-02 120 µL
ATP Synthase Subunit O, Mitochondrial (ATP5O) Antibody
Sign In for Pricing
View Details abx005681-03 200 µL
ATP Synthase Subunit O, Mitochondrial (ATP5O) Antibody
Sign In for Pricing
View Details 